The Workforce Intelligence Lab (WIL) is a research initiative of AlphaHire focused on applied workforce intelligence for the construction industry and built environment.
WIL develops workforce intelligence systems focused on:
The initiative combines publicly available labor data, compensation trends, contractor growth indicators, workforce demand signals, and construction activity into operational workforce intelligence systems for construction firms and industry operators.
Learn more:
WIL โ Workforce Intelligence Lab
We are seeking a Founding Director, Workforce Intelligence Research to help support and expand the Workforce Intelligence Lab (WIL).
This is a part-time, strategic leadership role focused on helping build the operational and institutional foundation of WIL as the initiative grows.
The ideal candidate is someone with experience in:
This role is not designed as a traditional academic position or recruiting role.
Instead, the position focuses on helping build:
Requirements
We are particularly interested in candidates with experience in:
Experience working within:
is highly relevant.
Benefits
WIL is currently focused on:
The initiative is being developed as:
NOT:
The long-term goal of WIL is to support:
The role is ideal for someone interested in helping shape an emerging workforce intelligence initiative focused on the built environment and construction industry.
The Research Director will lead efforts to understand and influence the governance and deployment of frontier AI technologies, collaborating with top experts and policymakers.
The Network Director โ ASEAN leads GRI's strategy in the region, focusing on increasing the uptake of GRI Standards, influencing policy, and building sustainable partnerships.
As the Director of GraphAware Solutions EMEA, you will drive growth by leading strategic sales initiatives and partnerships within the national security and intelligence sectors across Europe.
Lead a team of designers to create innovative user experiences that leverage AI and design thinking, transforming workplace collaboration for major enterprises.
The Obesity Therapeutic Area is seeking a Clinical Development Director to lead late phase studies in the maridebart cafraglutide (AMG 133) global development program for obesity and related metabolic diseases.
